HOME >> BIOLOGY >> NEWS
Research zeroes in on killer molecule in dioxin toxicity

(Blacksburg, Va., August 24, 1999) -- At Virginia Tech, Prakash and Mitzi Nagarkatti have discovered a step in dioxin toxicity that may enable them to develop diagnostic, treatment, and even prevention methods in the future. They received an $816,000 four-year grant from the National Institutes of Health this spring that will enable them to pursue research aimed at discovering ways to prevent the attachment of a killer molecule to other cells, or even prevent its activation by dioxins.

Dioxin is a highly toxic environmental pollutant formed as a byproduct during the manufacture and bleaching of paper. It is one of the most biologically potent chemicals, a member of the family of compounds known as halogenated aromatic hydrocarbons (which includes PCBs) that are found in herbicides, pesticides, automobile exhausts, and municipal and industrial waste, according to Prakash Nagarkatti, professor of biology.

Nagarkatti and Mitzi Nagarkatti, a professor in the Virginia-Maryland Regional College of Veterinary Medicine, have already shown in their lab that dioxin kills the immune cells using a unique process called apoptosis. "In this process," Prakash Nagarkatti said, "the cells commit suicide by destroying their own DNA." The Nagarkatti lab has identified a protein molecule involved in such killing, and dioxin treatment seems to activate the molecule, resulting in the killing of the immune cells.

The molecule, CD-95 ligand, is a member of a family of proteins that occurs naturally in the body, and its function is to kill cells that are not needed. The Nagarkattis were the first to demonstrate that the dioxin turned on the CD-95 ligand molecule in a way that it could not be turned off, and that the molecule then killed immune cells.

"It remains to be seen whether other related environmental pollutants use a similar mechanism to cause toxicity," Nagarkatti said. In the research funded by the latest NIH grant, the Nagarkattis will use antibodies to
'"/>

Contact: Dr. Prakash Nagarkatti
pnagarka@vt.edu
540-231-5029
Virginia Tech
24-Aug-1999


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research zeroes killer molecule dioxin toxicity

(Date:5/16/2013)... Bethesda, MD (May 17, 2013) Illustrating a ... the American Gastroenterological Association (AGA) Research Foundation ... Future Student Research Fellowship Award recipients. Supported by ... Kidney Diseases (NIDDK), this new award helps underrepresented ... digestive disease and nutrition research. , "By establishing ...
(Date:5/16/2013)... in neurodegenerative disease also plays a critical role in ... In a study of the common fruit fly, the ... responsible for sleeping and waking on a 24-hour rhythm. ... sleep-wake cycle is disturbed, making waking up on a ... discovery is particularly interesting because mutations in the human ...
(Date:5/16/2013)... Integrated Biometrics patented LES (Light Emitting ... film transistor camera introduces Sherlock, a fingerprint scanner ... the smallest and lightest form factor available on ... ID FAP 45, Certified scanner is highly efficient ... weight when compared to optical scanners. ...
Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2Gene involved in neurodegeneration keeps clock running 2
(Date:5/17/2013)... a world-leading provider of scientific, technical and medical information ... recent study in Reproductive BioMedicine Online ... with an abnormal chromosomal composition can be identified by ... thereby classifying the risk of genetic abnormality without a ... undertaken a retrospective study, using their predictive model to ...
(Date:5/17/2013)... TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... and insect pressures , Syngenta ... opening celebration today at the company’s RTP Innovation Center. ... Lab allows company researchers to simulate any agricultural climate ...
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce ... Switzerland -based Kenta Biotech to acquire ... (mAb) products, and technologies. This asset portfolio purchase ... of infections by common pathogens including drug resistant ... Pseudomonas aeruginosa , Acinetobacter baumannii and ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
Cached News: